Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Banco de datos
Tipo de estudio
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Biol Chem ; 298(5): 101850, 2022 05.
Artículo en Inglés | MEDLINE | ID: mdl-35339492

RESUMEN

Pyroptosis is an inflammatory form of programmed cell death that is executed by the gasdermin (GSDM)-N domain of GSDM family proteins, which form pores in the plasma membrane. Although pyroptosis acts as a host defense against invasive pathogen infection, its role in the pathogenesis of enterovirus 71 (EV71) infection is unclear. In the current study, we found that EV71 infection induces cleavage of GSDM E (GSDME) by using western blotting analysis, an essential step in the switch from caspase-3-mediated apoptosis to pyroptosis. We show that this cleavage is independent of the 3C and 2A proteases of EV71. However, caspase-3 activation is essential for this cleavage, as GSDME could not be cleaved in caspase-3-KO cells upon EV71 infection. Further analyses showed that EV71 infection induced pyroptosis in WT cells but not in caspase-3/GSDME double-KO cells. Importantly, GSDME is required to induce severe disease during EV71 infection, as GSDME deficiency in mice was shown to alleviate pathological symptoms. In conclusion, our results reveal that GSDME is important for the pathogenesis of EV71 via mediating initiation of pyroptosis.


Asunto(s)
Enterovirus Humano A , Infecciones por Enterovirus , Proteínas Citotóxicas Formadoras de Poros , Piroptosis , Animales , Apoptosis , Caspasa 3/genética , Caspasa 3/metabolismo , Muerte Celular , Enterovirus Humano A/fisiología , Infecciones por Enterovirus/metabolismo , Humanos , Ratones , Proteínas Citotóxicas Formadoras de Poros/metabolismo
2.
Sci Rep ; 12(1): 1397, 2022 01 26.
Artículo en Inglés | MEDLINE | ID: mdl-35082338

RESUMEN

Groundwater level has to be lowered during deep excavation. A vertical curtain is usually adopted to control the drawdown inside and outside a foundation pit in a built-up area. However, the cost and working difficulty increases substantially with the rise in depth of vertical curtains. In the manuscript, a man-made horizontal seepage reducing body (HSRB) was introduced to shorten the vertical curtain depth and control drawdown. With the No. 4 shaft foundation pit of Guangyuan Project, Shanghai as background, HSRB was proposed in foundation pit dewatering. Microbially induced carbonate precipitation grouting technology was recommended to form an environment-friendly HSRB. Numerical method was used to simulate and understand the influence of position, thickness, and hydraulic conductivity of HSRB on groundwater level. The non-separated HSRB was better than the separate HSRB. Decreasing HSRB hydraulic conductivity was better than increasing HSRB depth. Four seepage modes were summarized considering vertical curtain penetration conditions into multi-aquifer, and the fifth seepage mode was formed for vertical curtain using man-made HSRB, which can be referred by similar engineering applications.

3.
Signal Transduct Target Ther ; 7(1): 44, 2022 02 09.
Artículo en Inglés | MEDLINE | ID: mdl-35140196

RESUMEN

The wide transmission and host adaptation of SARS-CoV-2 have led to the rapid accumulation of mutations, posing significant challenges to the effectiveness of vaccines and therapeutic antibodies. Although several neutralizing antibodies were authorized for emergency clinical use, convalescent patients derived natural antibodies are vulnerable to SARS-CoV-2 Spike mutation. Here, we describe the screen of a panel of SARS-CoV-2 receptor-binding domain (RBD) targeted nanobodies (Nbs) from a synthetic library and the design of a biparatopic Nb, named Nb1-Nb2, with tight affinity and super-wide neutralization breadth against multiple SARS-CoV-2 variants of concern. Deep-mutational scanning experiments identify the potential binding epitopes of the Nbs on the RBD and demonstrate that biparatopic Nb1-Nb2 has a strong escape-resistant feature against more than 60 tested RBD amino acid substitutions. Using pseudovirion-based and trans-complementation SARS-CoV-2 tools, we determine that the Nb1-Nb2 broadly neutralizes multiple SARS-CoV-2 variants at sub-nanomolar levels, including Alpha (B.1.1.7), Beta (B.1.351), Gamma (P.1), Delta (B.1.617.2), Lambda (C.37), Kappa (B.1.617.1), and Mu (B.1.621). Furthermore, a heavy-chain antibody is constructed by fusing the human IgG1 Fc to Nb1-Nb2 (designated as Nb1-Nb2-Fc) to improve its neutralization potency, yield, stability, and potential half-life extension. For the new Omicron variant (B.1.1.529) that harbors unprecedented multiple RBD mutations, Nb1-Nb2-Fc keeps a firm affinity (KD < 1.0 × 10-12 M) and strong neutralizing activity (IC50 = 1.46 nM for authentic Omicron virus). Together, we developed a tetravalent biparatopic human heavy-chain antibody with ultrapotent and broad-spectrum SARS-CoV-2 neutralization activity which highlights the potential clinical applications.


Asunto(s)
Anticuerpos Neutralizantes/farmacología , Anticuerpos Antivirales/farmacología , Fragmentos Fc de Inmunoglobulinas/farmacología , Proteínas Recombinantes de Fusión/farmacología , SARS-CoV-2/efectos de los fármacos , Anticuerpos de Dominio Único/farmacología , Anticuerpos Neutralizantes/biosíntesis , Anticuerpos Neutralizantes/genética , Anticuerpos Antivirales/biosíntesis , Anticuerpos Antivirales/genética , Afinidad de Anticuerpos , Ensayo de Inmunoadsorción Enzimática , Epítopos/química , Epítopos/inmunología , Escherichia coli/genética , Escherichia coli/metabolismo , Expresión Génica , Humanos , Fragmentos Fc de Inmunoglobulinas/biosíntesis , Fragmentos Fc de Inmunoglobulinas/genética , Modelos Moleculares , Pruebas de Neutralización , Unión Proteica/efectos de los fármacos , Conformación Proteica , Dominios y Motivos de Interacción de Proteínas , Proteínas Recombinantes de Fusión/biosíntesis , Proteínas Recombinantes de Fusión/genética , SARS-CoV-2/crecimiento & desarrollo , SARS-CoV-2/inmunología , Anticuerpos de Dominio Único/biosíntesis , Anticuerpos de Dominio Único/genética , Glicoproteína de la Espiga del Coronavirus/antagonistas & inhibidores , Glicoproteína de la Espiga del Coronavirus/química , Glicoproteína de la Espiga del Coronavirus/genética , Glicoproteína de la Espiga del Coronavirus/inmunología
4.
Signal Transduct Target Ther ; 6(1): 382, 2021 11 03.
Artículo en Inglés | MEDLINE | ID: mdl-34732709

RESUMEN

The global coronavirus disease 2019 (COVID-19) pandemic is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a positive-sense RNA virus. How the host immune system senses and responds to SARS-CoV-2 infection remain largely unresolved. Here, we report that SARS-CoV-2 infection activates the innate immune response through the cytosolic DNA sensing cGAS-STING pathway. SARS-CoV-2 infection induces the cellular level of 2'3'-cGAMP associated with STING activation. cGAS recognizes chromatin DNA shuttled from the nucleus as a result of cell-to-cell fusion upon SARS-CoV-2 infection. We further demonstrate that the expression of spike protein from SARS-CoV-2 and ACE2 from host cells is sufficient to trigger cytoplasmic chromatin upon cell fusion. Furthermore, cytoplasmic chromatin-cGAS-STING pathway, but not MAVS-mediated viral RNA sensing pathway, contributes to interferon and pro-inflammatory gene expression upon cell fusion. Finally, we show that cGAS is required for host antiviral responses against SARS-CoV-2, and a STING-activating compound potently inhibits viral replication. Together, our study reported a previously unappreciated mechanism by which the host innate immune system responds to SARS-CoV-2 infection, mediated by cytoplasmic chromatin from the infected cells. Targeting the cytoplasmic chromatin-cGAS-STING pathway may offer novel therapeutic opportunities in treating COVID-19. In addition, these findings extend our knowledge in host defense against viral infection by showing that host cells' self-nucleic acids can be employed as a "danger signal" to alarm the immune system.


Asunto(s)
COVID-19/inmunología , Cromatina/inmunología , Citoplasma/inmunología , Inmunidad Innata , Nucleotidiltransferasas/inmunología , SARS-CoV-2/inmunología , Animales , COVID-19/genética , Cromatina/genética , Citoplasma/genética , Modelos Animales de Enfermedad , Células HEK293 , Células HeLa , Humanos , Ratones , Ratones Transgénicos , Nucleotidiltransferasas/genética , SARS-CoV-2/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA